Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ketonuria is not associated with hyperemesis gravidarum disease severity.
Koot MH, Grooten IJ, Post JAMV, Bais JMJ, Ris-Stalpers C, Naaktgeboren CA, Niemeijer MN, Bremer HA, van der Ham DP, Heidema WM, Huisjes A, Kleiverda G, Kuppens SM, van Laar JOEH, Langenveld J, van der Made F, Papatsonis D, Pelinck MJ, Pernet PJ, van Rheenen-Flach L, Rijnders RJ, Scheepers HCJ, Vogelvang TE, Mol BW, Roseboom TJ, Painter RC. Koot MH, et al. Among authors: heidema wm. Eur J Obstet Gynecol Reprod Biol. 2020 Nov;254:315-320. doi: 10.1016/j.ejogrb.2020.08.014. Epub 2020 Aug 26. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 33045502
Early nasogastric tube feeding in optimising treatment for hyperemesis gravidarum: the MOTHER randomised controlled trial (Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding).
Grooten IJ, Mol BW, van der Post JAM, Ris-Stalpers C, Kok M, Bais JMJ, Bax CJ, Duvekot JJ, Bremer HA, Porath MM, Heidema WM, Bloemenkamp KWM, Scheepers HCJ, Franssen MTM, Oudijk MA, Roseboom TJ, Painter RC. Grooten IJ, et al. Among authors: heidema wm. BMC Pregnancy Childbirth. 2016 Jan 27;16:22. doi: 10.1186/s12884-016-0815-1. BMC Pregnancy Childbirth. 2016. PMID: 26819104 Free PMC article. Clinical Trial.
Early enteral tube feeding in optimizing treatment of hyperemesis gravidarum: the Maternal and Offspring outcomes after Treatment of HyperEmesis by Refeeding (MOTHER) randomized controlled trial.
Grooten IJ, Koot MH, van der Post JA, Bais JM, Ris-Stalpers C, Naaktgeboren C, Bremer HA, van der Ham DP, Heidema WM, Huisjes A, Kleiverda G, Kuppens S, van Laar JO, Langenveld J, van der Made F, van Pampus MG, Papatsonis D, Pelinck MJ, Pernet PJ, van Rheenen L, Rijnders RJ, Scheepers HC, Vogelvang TE, Mol BW, Roseboom TJ, Painter RC. Grooten IJ, et al. Among authors: heidema wm. Am J Clin Nutr. 2017 Sep;106(3):812-820. doi: 10.3945/ajcn.117.158931. Epub 2017 Aug 9. Am J Clin Nutr. 2017. PMID: 28793989 Free article. Clinical Trial.
Determinants of disease course and severity in hyperemesis gravidarum.
Koot MH, Grooten IJ, van der Post JAM, Bais JMJ, Ris-Stalpers C, Leeflang MMG, Bremer HA, van der Ham DP, Heidema WM, Huisjes A, Kleiverda G, Kuppens SM, van Laar JOEH, Langenveld J, van der Made F, van Pampus MG, Papatsonis D, Pelinck MJ, Pernet PJ, van Rheenen-Flach L, Rijnders RJ, Scheepers HCJ, Vogelvang TE, Mol BW, Roseboom TJ, Painter RC. Koot MH, et al. Among authors: heidema wm. Eur J Obstet Gynecol Reprod Biol. 2020 Feb;245:162-167. doi: 10.1016/j.ejogrb.2019.12.021. Epub 2019 Dec 24. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 31923736
Thyroid-stimulating hormone and free thyroxine fail to predict the severity and clinical course of hyperemesis gravidarum: A prospective cohort study.
Nijsten K, Koot MH, van der Post JAM, Bais JMJ, Ris-Stalpers C, Naaktgeboren C, Bremer HA, van der Ham DP, Heidema WM, Huisjes A, Kleiverda G, Kuppens SM, van Laar JOEH, Langenveld J, van der Made F, Papatsonis D, Pelinck MJ, Pernet PJ, van Rheenen-Flach L, Rijnders RJ, Scheepers HCJ, Siegelaar SE, Vogelvang T, Mol BW, Roseboom TJ, Grooten IJ, Painter RC. Nijsten K, et al. Among authors: heidema wm. Acta Obstet Gynecol Scand. 2021 Aug;100(8):1419-1429. doi: 10.1111/aogs.14131. Epub 2021 Mar 12. Acta Obstet Gynecol Scand. 2021. PMID: 33606270 Free PMC article.
Recurrence, postponing pregnancy, and termination rates after hyperemesis gravidarum: Follow up of the MOTHER study.
Nijsten K, Dean C, van der Minnen LM, Bais JMJ, Ris-Stalpers C, van Eekelen R, Bremer HA, van der Ham DP, Heidema WM, Huisjes A, Kleiverda G, Kuppens SM, van Laar JOEH, Langenveld J, van der Made F, Papatsonis D, Pelinck MJ, Pernet PJ, van Rheenen-Flach L, Rijnders RJ, Scheepers HCJ, Vogelvang T, Mol BW, Roseboom TJ, Koot MH, Grooten IJ, Painter RC. Nijsten K, et al. Among authors: heidema wm. Acta Obstet Gynecol Scand. 2021 Sep;100(9):1636-1643. doi: 10.1111/aogs.14197. Epub 2021 Jun 26. Acta Obstet Gynecol Scand. 2021. PMID: 34033123 Free PMC article.
Hyperemesis gravidarum severity, enteral tube feeding and cardiometabolic markers in offspring cord blood.
Nijsten K, Koot MH, Bais JMJ, Ris-Stalpers C, van Eekelen R, Bremer HA, van der Ham DP, Heidema WM, Huisjes A, Kleiverda G, Kruizenga H, Kuppens SM, van Laar JOEH, Langenveld J, van der Made F, Papatsonis D, Pelinck MJ, Pernet PJ, van Rheenen-Flach L, Rijnders RJ, Scheepers HCJ, Vogelvang T, Mol BW, Grooten IJ, Roseboom TJ, Painter RC. Nijsten K, et al. Among authors: heidema wm. Br J Nutr. 2022 Dec 28;128(12):2421-2431. doi: 10.1017/S0007114522000587. Epub 2022 Feb 24. Br J Nutr. 2022. PMID: 35197140 Free PMC article.
Depression, anxiety, and post-traumatic stress disorder symptoms after hyperemesis gravidarum: a prospective cohort study.
Nijsten K, van der Minnen LM, Dean C, Bais JMJ, Ris-Stalpers C, van Eekelen R, Bremer HA, van der Ham DP, Heidema WM, Huisjes A, Kleiverda G, Kuppens SM, van Laar JOEH, Langenveld J, van der Made F, Papatsonis D, Pelinck MJ, Pernet PJ, van Rheenen-Flach L, Rijnders RJ, Scheepers HCJ, Vogelvang T, Mol BW, Olff M, Roseboom TJ, Koot MH, Grooten IJ, Painter RC. Nijsten K, et al. Among authors: heidema wm. J Matern Fetal Neonatal Med. 2022 Dec;35(25):10055-10063. doi: 10.1080/14767058.2022.2089550. Epub 2022 Jun 21. J Matern Fetal Neonatal Med. 2022. PMID: 35726837 Clinical Trial.
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial.
Bistervels IM, Buchmüller A, Wiegers HMG, Ní Áinle F, Tardy B, Donnelly J, Verhamme P, Jacobsen AF, Hansen AT, Rodger MA, DeSancho MT, Shmakov RG, van Es N, Prins MH, Chauleur C, Middeldorp S; Highlow Block writing committee; Highlow Investigators. Bistervels IM, et al. Lancet. 2022 Nov 19;400(10365):1777-1787. doi: 10.1016/S0140-6736(22)02128-6. Epub 2022 Oct 28. Lancet. 2022. PMID: 36354038 Clinical Trial.
25 results